European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Effects of a High-Prebiotic Diet versus Synbiotics on Mental Health April 7, 2023 Effect of a Supplement Containing Probiotics, Prebiotics, and Yeast Extract on Gut Inflammation, Microbiota, and Cytokines in Healthy Dogs January 16, 2026 Mushrooms blend dose-dependently increases butyrate production by the gut microbiota November 5, 2021
Effect of a Supplement Containing Probiotics, Prebiotics, and Yeast Extract on Gut Inflammation, Microbiota, and Cytokines in Healthy Dogs January 16, 2026
Mushrooms blend dose-dependently increases butyrate production by the gut microbiota November 5, 2021